Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001493152-25-004486

CHAIRMAN AND CEO bought 346,844 shares at $0.03 ($9,712)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Trieu Vuong CHAIRMAN AND CEO 2025-01-29 Purchase +183,066 $0.03 $5,126 93,025,782 D: show line 1 in the form
Trieu Vuong CHAIRMAN AND CEO 2025-01-30 Purchase +100,003 $0.03 $2,800 93,125,785 D: show line 2 in the form
Trieu Vuong CHAIRMAN AND CEO 2025-01-31 Purchase +63,775 $0.03 $1,786 93,189,560 D: show line 3 in the form
Open-market purchases · 346,844 sh · avg $0.03 · $9,712
Loading xslF345X05/ownership.xml…